Details for New Drug Application (NDA): 021745
✉ Email this page to a colleague
The generic ingredient in RYZOLT is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Forty-eight suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.
Summary for 021745
Tradename: | RYZOLT |
Applicant: | Purdue Pharma |
Ingredient: | tramadol hydrochloride |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 021745
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 30, 2008 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 30, 2008 | TE: | RLD: | Yes |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Dec 30, 2008 | TE: | RLD: | Yes |
Expired US Patents for NDA 021745
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Purdue Pharma | RYZOLT | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021745-001 | Dec 30, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma | RYZOLT | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021745-003 | Dec 30, 2008 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma | RYZOLT | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021745-001 | Dec 30, 2008 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription